Vertex Pharma (VRTX)
516.18
+1.53 (0.30%)
Upcoming Events
Latest Headlines
Form 8-K VERTEX PHARMACEUTICALS For: Oct 20
October 20, 2026 4:09 PM - SEC Filing
Vertex Pharmaceuticals adds ex-Boston Scientific CFO to its board
October 20, 2026 4:05 PM - StreetInsider
Vertex Appoints Daniel Brennan to its Board of Directors
October 20, 2026 4:05 PM - BizWire
Form 4 VERTEX PHARMACEUTICALS For: Oct 15 Filed by: SACHS BRUCE I
October 19, 2026 4:23 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Oct 15 Filed by: Garber Alan M
October 19, 2026 4:21 PM - SEC Filing
Vortex Energy Corp. Announces Extension of Marketing Program
October 15, 2026 5:00 PM - Globe NewsWire
Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print'
October 12, 2026 9:04 AM - StreetInsider
Vertex (VRTX) PT Lowered to $667 at BofA Securities
October 12, 2026 6:16 AM - StreetInsider
Vertex reports Alyftrek may reverse pancreatic insufficiency in young CF patients
October 9, 2026 1:15 PM - StreetInsider
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference
October 9, 2026 1:15 PM - BizWire
Raymond James sees strong demand for APOL1-mediated FSGS therapies
October 9, 2026 5:52 AM - StreetInsider
Vertex (VRTX) PT Raised to $576 at RBC Capital
October 8, 2026 8:26 AM - StreetInsider
Vertex to Announce Third Quarter 2026 Financial Results November 2nd
October 7, 2026 4:00 PM - BizWire
Vortex Energy Commissions Hydrogen and Helium Study at Robinsons River Salt Project
October 5, 2026 8:00 AM - Globe NewsWire
Vortex Energy acquires Meadows Project in Saskatchewan
October 1, 2026 5:00 PM - StreetInsider
Vortex Energy Completes Acquisition of the Meadows Project in Saskatchewan
October 1, 2026 5:00 PM - Globe NewsWire
Vertex (VRTX) PT Raised to $615 at UBS
September 28, 2026 9:40 AM - StreetInsider
Vertex (VRTX) PT Raised to $640 at Jefferies
September 23, 2026 5:27 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)
September 22, 2026 10:21 AM - StreetInsider
BMO Capital Reiterates Outperform Rating on Vertex (VRTX)
September 22, 2026 10:21 AM - StreetInsider
Stifel Reiterates Hold Rating on Vertex (VRTX)
September 22, 2026 9:28 AM - StreetInsider
Vertex reports Phase 2b kidney disease drug data, enrolls Phase 2/3 trial
September 22, 2026 8:00 AM - StreetInsider
Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3
September 22, 2026 8:00 AM - BizWire
Leerink Resumes Vertex (VRTX) at Outperform
September 21, 2026 6:06 AM - StreetInsider
Vortex Energy agrees to buy Saskatchewan mineral permit for C$255,000
September 17, 2026 5:30 PM - StreetInsider
Vortex Energy Enters Into Asset Purchase Agreement to Acquire the Meadows Project in Saskatchewan
September 17, 2026 5:30 PM - Globe NewsWire
Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain
September 15, 2026 7:30 AM - BizWire
Vortex Energy Engages Lonquist to Manage Ground Gravity Survey at the Robinsons River Salt Project
September 14, 2026 8:00 AM - Globe NewsWire
Form 4 VERTEX PHARMACEUTICALS For: Sep 08 Filed by: van Grunsven Jasper
September 10, 2026 4:32 PM - SEC Filing
Form 3 VERTEX PHARMACEUTICALS For: Sep 08 Filed by: van Grunsven Jasper
September 10, 2026 4:16 PM - SEC Filing
Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick
September 8, 2026 9:00 AM - StreetInsider
Vortex Energy Announces Plans for Ground Gravity Survey at the Robinsons River Salt Project
September 3, 2026 8:00 AM - Globe NewsWire
Morgan Stanley Resumes Vertex (VRTX) at Overweight
September 1, 2026 4:48 PM - StreetInsider
Goldman Sachs refreshes conviction lists on both sides of the Atlantic
September 1, 2026 1:41 PM - StreetInsider
Goldman Sachs Adjust Monthly US Director's Cut List
September 1, 2026 5:31 AM - StreetInsider
Form 144 VERTEX PHARMACEUTICALS Filed by: SACHS BRUCE I
August 27, 2026 4:47 PM - SEC Filing
Vertex to Participate in Upcoming September Investor Conferences
August 26, 2026 4:00 PM - BizWire
Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project
August 18, 2026 8:00 AM - Globe NewsWire
Vortex Energy Engages Market Maker
August 17, 2026 8:01 AM - Globe NewsWire
RBC Capital on Vertex (VRTX): 'SION Overhang Cleared; We Would Remain Buyers'
August 12, 2026 8:50 AM - StreetInsider
Bernstein SocGen Reiterates Outperform Rating on Vertex (VRTX)
August 11, 2026 9:38 AM - StreetInsider
Vertex Pharma (VRTX) Added to BofA US 1 List
August 11, 2026 5:28 AM - StreetInsider
Vertex (VRTX) PT Raised to $562 at Wolfe Research
August 10, 2026 12:24 PM - StreetInsider
Vertex stock jumps as rival cystic fibrosis drug fails trial
August 10, 2026 10:01 AM - StreetInsider
BMO Capital Reiterates Outperform Rating on Vertex (VRTX) After Rival Fails
August 10, 2026 9:58 AM - StreetInsider
Morgan Stanley tracks US drug market prescriptions for week ending July 31
August 7, 2026 12:04 PM - StreetInsider
Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt Project
August 6, 2026 8:00 AM - Globe NewsWire
Vertex (VRTX) PT Raised to $617 at Barclays
August 5, 2026 4:30 AM - StreetInsider
Form 10-Q VERTEX PHARMACEUTICALS For: Jun 30
August 4, 2026 4:09 PM - SEC Filing
Vertex (VRTX) PT Raised to $500 at Stifel
August 4, 2026 8:49 AM - StreetInsider
Vertex (VRTX) PT Raised to $550 at TD Cowen
August 4, 2026 8:12 AM - StreetInsider
Vertex (VRTX) PT Raised to $595 at Cantor Fitzgerald on Uniquely Attractive Optionality
August 4, 2026 7:59 AM - StreetInsider
Vertex (VRTX) PT Lowered to $570 at RBC Capital
August 4, 2026 7:05 AM - StreetInsider
Vertex (VRTX) PT Raised to $442 at Canaccord
August 4, 2026 6:44 AM - StreetInsider
Form 8-K VERTEX PHARMACEUTICALS For: Aug 03
August 3, 2026 4:10 PM - SEC Filing
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 3, 2026 4:05 PM - StreetInsider
Vertex Pharma (VRTX) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
August 3, 2026 4:02 PM - StreetInsider
Vertex Reports Second Quarter 2026 Financial Results
August 3, 2026 4:01 PM - BizWire
AbCellera and Vertex team up on T-cell engager drugs for autoimmune
July 29, 2026 7:00 AM - StreetInsider
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
July 29, 2026 7:00 AM - BizWire
Vortex Energy Corp. Announces Marketing Program
July 24, 2026 5:00 PM - Globe NewsWire
Form 4 VERTEX PHARMACEUTICALS For: Jul 21 Filed by: Tatsis Ourania
July 23, 2026 4:16 PM - SEC Filing
Form 4 VERTEX PHARMACEUTICALS For: Jul 21 Filed by: Sachdev Amit
July 23, 2026 4:13 PM - SEC Filing
Full Article List
